CareDx Current Ratio 2013-2025 | CDNA

CareDx current ratio from 2013 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
CareDx Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2025-03-31 $0.35B $0.09B 4.11
2024-12-31 $0.35B $0.09B 3.94
2024-09-30 $0.33B $0.08B 4.10
2024-06-30 $0.32B $0.08B 4.09
2024-03-31 $0.30B $0.07B 4.32
2023-12-31 $0.31B $0.08B 4.02
2023-09-30 $0.35B $0.07B 4.75
2023-06-30 $0.36B $0.07B 4.84
2023-03-31 $0.37B $0.07B 5.17
2022-12-31 $0.39B $0.08B 5.11
2022-09-30 $0.39B $0.07B 5.52
2022-06-30 $0.40B $0.08B 5.15
2022-03-31 $0.41B $0.07B 6.15
2021-12-31 $0.43B $0.08B 5.61
2021-09-30 $0.45B $0.07B 6.38
2021-06-30 $0.44B $0.06B 7.84
2021-03-31 $0.44B $0.05B 9.59
2020-12-31 $0.27B $0.07B 3.95
2020-09-30 $0.26B $0.06B 4.14
2020-06-30 $0.25B $0.06B 4.42
2020-03-31 $0.07B $0.03B 2.33
2019-12-31 $0.07B $0.04B 2.07
2019-09-30 $0.07B $0.03B 2.20
2019-06-30 $0.07B $0.03B 2.39
2019-03-31 $0.08B $0.02B 4.74
2018-12-31 $0.08B $0.02B 4.16
2018-09-30 $0.04B $0.02B 2.65
2018-06-30 $0.03B $0.01B 2.16
2018-03-31 $0.03B $0.01B 2.43
2017-12-31 $0.03B $0.04B 0.62
2017-09-30 $0.02B $0.03B 0.55
2017-06-30 $0.02B $0.05B 0.37
2017-03-31 $0.02B $0.05B 0.44
2016-12-31 $0.03B $0.04B 0.65
2016-09-30 $0.04B $0.04B 0.89
2016-06-30 $0.03B $0.04B 0.85
2016-03-31 $0.03B $0.01B 1.94
2015-12-31 $0.03B $0.01B 3.39
2015-09-30 $0.04B $0.01B 3.63
2015-06-30 $0.04B $0.01B 4.85
2015-03-31 $0.04B $0.01B 6.74
2014-12-31 $0.04B $0.01B 3.62
2014-09-30 $0.04B $0.01B 3.78
2014-06-30 $0.01B $0.02B 0.64
2014-03-31 $0.01B $0.01B 0.90
2013-12-31 $0.01B $0.01B 1.08
2013-09-30 $0.00B 0.00
2013-06-30 $0.00B 0.00
2013-03-31 $0.00B 0.00
2012-12-31 $0.01B $0.01B 1.18
Sector Industry Market Cap Revenue
Medical Medical Services $0.977B $0.334B
CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $140.350B 26.32
Elevance Health (ELV) United States $91.117B 11.76
CVS Health (CVS) United States $79.102B 9.83
Cencora (COR) United States $56.251B 19.57
DiDi Global (DIDIY) China $21.979B 33.36
Natera (NTRA) United States $20.836B 0.00
BioMerieux (BMXMF) France $15.355B 0.00
Solventum (SOLV) United States $12.822B 13.57
EUROFINS SCIENT (ERFSF) Luxembourg $12.604B 0.00
CochLear (CHEOY) Australia $11.282B 0.00
Revvity (RVTY) United States $10.993B 18.92
ICON (ICLR) Ireland $10.630B 9.88
Viatris (VTRS) United States $10.375B 3.56
Doximity (DOCS) United States $9.813B 45.70
Avantor (AVTR) United States $9.138B 13.28
Medpace Holdings (MEDP) United States $8.785B 23.33
HealthEquity (HQY) United States $8.497B 41.80
Sonic Healthcare (SKHHY) Australia $8.220B 0.00
Charles River Laboratories (CRL) United States $6.924B 13.57
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
BrightSpring Health Services (BTSG) United States $4.257B 39.40
Bausch + Lomb (BLCO) Canada $4.156B 24.50
Sotera Health (SHC) United States $3.633B 20.65
Alignment Healthcare (ALHC) United States $3.122B 0.00
Surgery Partners (SGRY) United States $3.068B 39.90
Concentras Parent (CON) United States $2.912B 16.83
Organon (OGN) United States $2.350B 2.50
Ardent Health Partners (ARDT) United States $2.204B 9.40
GeneDx Holdings (WGS) United States $1.949B 75.07
Progyny (PGNY) United States $1.912B 42.08
Premier (PINC) United States $1.904B 14.45
PACS (PACS) United States $1.647B 0.00
GoodRx Holdings (GDRX) United States $1.414B 28.29
Teladoc Health (TDOC) United States $1.319B 0.00
Pediatrix Medical (MD) United States $1.283B 9.76
Establishment Labs Holdings (ESTA) $1.046B 0.00
Agilon Health (AGL) United States $1.014B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.998B 0.00
Nutex Health (NUTX) United States $0.972B 14.69
AMN Healthcare Services Inc (AMN) United States $0.869B 8.13
QDM (QDMI) Hong Kong, SAR China $0.729B 0.00
Embecta (EMBC) United States $0.702B 4.73
InnovAge Holding (INNV) United States $0.566B 0.00
Enhabit (EHAB) United States $0.539B 44.33
Auna S.A (AUNA) Luxembourg $0.514B 13.63
Sonida Senior Living (SNDA) United States $0.494B 0.00
LifeMD (LFMD) United States $0.487B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.370B 0.00
SBC Medicals (SBC) United States $0.352B 0.00
Oncology Institute (TOI) United States $0.226B 0.00
Beauty Health (SKIN) United States $0.218B 0.00
Performant Healthcare (PHLT) United States $0.209B 0.00
DocGo (DCGO) United States $0.150B 24.50
Sera Prognostics (SERA) United States $0.087B 0.00
So-Young (SY) China $0.084B 0.00
OncoCyte (OCX) United States $0.080B 0.00
KindlyMD (KDLY) United States $0.078B 0.00
Ascend Wellness Holdings (AAWH) United States $0.065B 0.00
NeueHealth (NEUE) United States $0.062B 0.00
IceCure Medical (ICCM) Israel $0.058B 0.00
Biodesix (BDSX) United States $0.044B 0.00
Basel Medical Group (BMGL) Singapore $0.044B 0.00
Pheton Holdings (PTHL) China $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.033B 0.00
ModivCare (MODV) United States $0.013B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00